Your browser doesn't support javascript.
loading
Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
Conde-Moreno, Antonio José; González-Del-Alba, Aránzazu; López-Campos, Fernando; López López, Carlos; Requejo, Ovidio Hernando; de Castro Carpeño, Javier; Chicas-Sett, Rodolfo; de Paz Arias, Laura; Montero-Luis, Ángel; Pérez, Aurora Rodríguez; Font, Enriqueta Felip; Arija, José Ángel Arranz.
Afiliação
  • Conde-Moreno AJ; Radiation Oncology Department, Hospital Universitari i Politècnic La Fe, Avinguda de Fernando Abril Martorell, 106, 46026, Valencia, Spain. antoniojconde@gmail.com.
  • González-Del-Alba A; Medical Oncology Department, Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • López-Campos F; Radiation Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • López López C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Requejo OH; Radiation Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • de Castro Carpeño J; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Chicas-Sett R; Department of Radiation Oncology, ASCIRES Grupo Biomédico, Valencia, Spain.
  • de Paz Arias L; Medical Oncology Department, Complejo Hospitalario Universitario de Ferrol, La Coruña, Spain.
  • Montero-Luis Á; Radiation Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Pérez AR; Radiation Oncology, Hospital Ruber Internacional, Madrid, Spain.
  • Font EF; Medical Oncology, Hospital Universitario del Vall d'Hebron, Barcelona, Spain.
  • Arija JÁA; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Clin Transl Oncol ; 25(4): 897-911, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36525230
Oligometastatic disease (OMD) defines a status of cancer that is intermediate between localized and widely spread metastatic disease, and can be treated with curative intent. While imaging diagnostic tools have considerably improved in recent years, unidentified micrometastases can still escape from current detection techniques allowing disease to progress. The variety of OMD scenarios are mainly defined by the number of metastases, the biological and molecular tumour profiles, and the timing of the development of metastases. Increasing knowledge has contributed to the earlier and improved detection of OMD, underlining the importance of an early disease control. Based on increasing detection rates of OMD in the current real clinical practice and the lack of standardized evidence-based guidelines to treat this cancer status, a board of experts from the Spanish Societies of Radiation Oncology (SEOR) and Medical Oncology (SEOM) organized a series of sessions to update the current state-of-the-art on OMD from a multidisciplinary perspective, and to discuss how results from clinical studies may translate into promising treatment options. This experts' review series summarizes what is known and what it is pending clarification in the context of OMD in the scenarios of Non-Small Cell Lung Cancer and Breast Cancer (Part I), and Prostate Cancer and Colorectal Cancer (Part II), aiming to offer specialists a pragmatic framework that might contribute to the improved management of patients.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Colorretais / Radiocirurgia / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha País de publicação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Colorretais / Radiocirurgia / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha País de publicação: Itália